Predictors of the response to adalimumab in rheumatoid arthritis.
Phase of Trial: Phase IV
Latest Information Update: 16 Sep 2014
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 08 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Feb 2009 Planned number of patients changed to 200 as reported by ClinicalTrials.gov.
- 04 Dec 2005 New trial record.